Monsanto, Myriad: Two US Legal Cases Shaking Biotech Industries 18/02/2013 by Catherine Saez, Intellectual Property Watch 4 Comments The biotechnology industry has growing concerns over decisions to be taken this year by the United States Supreme Court in two cases involving the patenting of human genes and the exhaustion of patent rights in the context of easily reproducible products. Several areas of biotechnology could be affected by unfavourable decisions, provoking legal uncertainty and discouraging innovation, industry representatives said in a recent telephone conference. In the meantime, civil society stands fast in opposition.
UN Takes On Organised Crime And Fraudulent Medicines 15/02/2013 by William New and Tiphaine Nunzia Caulier for Intellectual Property Watch 2 Comments The United Nations has become a focal point for global efforts to fight organised crime’s trafficking of fraudulent medicines that put millions of people – especially the poor – at risk. And a recent pharmaceutical industry report on such medicines recommended some solutions.
USPTO Finalises Rules For ‘First-Inventor-To-File’ System Switch 13/02/2013 by Kelly Burke for Intellectual Property Watch 1 Comment The United States Patent and Trademark Office (USPTO) today published final rules of practice implementing the “first-inventor-to-file” provision of the Leahy-Smith America Invents Act (AIA). This comes just days after a change in patent fees.
WIPO Side Event Addresses Recent Developments Related To The Nagoya Protocol 13/02/2013 by Tiphaine Nunzia Caulier for Intellectual Property Watch 1 Comment At the World Intellectual Property Organization meeting on protection of genetic resources last week, the secretariat of the UN Convention on Biological Diversity (CBD) organised a side event to introduce the key features and recent developments of the international protocol on access and benefit-sharing of such resources.
Texts Show Details Of EU Parliament Transparency Directive Vote 13/02/2013 by Intellectual Property Watch Leave a Comment The European Parliament last week overwhelmingly adopted a text on transparency that was said to improve conditions for generic medicines in the region. The voting documents are now available.
Letter Shows US Pressure On Global Fund For Compulsory Licensing, Generics 12/02/2013 by William New, Intellectual Property Watch Leave a Comment A 2011 letter from the top Republican on the United States Senate Finance Committee condemned efforts by the Global Fund to train public health officials on the use of flexibilities to the patent system contained in international trade rules. The letter, which also attacked the purchase of generic medicines over brand-name drugs, came just months before the US helped remove the head of the Global Fund, ultimately replacing him with an American official.
Year Ahead In IP, Biotech, Biodiversity: A Trio Fuelling Debates, Opportunities In 2013 12/02/2013 by Catherine Saez, Intellectual Property Watch Leave a Comment The coming year promises to be very interesting at the intersection of intellectual property with biotechnology and biodiversity. Patentability of human genes in the United States, of conventionally bred plants in Europe, plant breeders’ rights and the management of regulatory authorisations when patents on genetic traits expire, the future of genetically modified organisms in developing countries, and the usual resistance they are meeting from civil society and famers’ groups are some of the issues that will continue to feed debates – and potentially create opportunities – in 2013.
Report Proposes Solutions To Address Non-Communicable Diseases 11/02/2013 by Tiphaine Nunzia Caulier for Intellectual Property Watch 1 Comment An industry-backed group of experts has issued a report identifying significant obstacles to addressing non-communicable diseases (NCDs) and proposing solutions to reduce premature deaths caused by NCDs.
Draft Text On Protection Of Genetic Resources On Its Way To WIPO Assembly 08/02/2013 by Catherine Saez, Intellectual Property Watch 4 Comments At the end of a weeklong drafting exercise, World Intellectual Property Organization delegates have produced a text on the protection of genetic resources that appears to be headed to the organisation’s annual General Assembly next September. And some members hope that a high-level meeting will be convened in the course of 2014 to agree on an international instrument or instruments protecting genetic resources against misappropriation.
WIPO Update: Improved Text On Genetic Resources; Disclosure Still Undecided 08/02/2013 by Catherine Saez, Intellectual Property Watch 2 Comments The second revision of a text on the protection of genetic resources was provided to the World Intellectual Property Organization country delegates this morning. The document, which has been streamlined by facilitators, contains a number of bracketed text, showing divergences which will require further work, including resolving how to track origin of genetic material in patent applications.